From owner-freebsd-virtualization@freebsd.org Tue Feb 23 08:03:16 2016 Return-Path: Delivered-To: freebsd-virtualization@mailman.ysv.freebsd.org Received: from mx1.freebsd.org (mx1.freebsd.org [IPv6:2001:1900:2254:206a::19:1]) by mailman.ysv.freebsd.org (Postfix) with ESMTP id 22B85AB1199 for ; Tue, 23 Feb 2016 08:03:16 +0000 (UTC) (envelope-from bouncer@me22564.mailengine1.com) Received: from me22564.mailengine1.com (me22564.mailengine1.com [72.19.229.130]) by mx1.freebsd.org (Postfix) with ESMTP id 8E5D31A29 for ; Tue, 23 Feb 2016 08:03:05 +0000 (UTC) (envelope-from bouncer@me22564.mailengine1.com) Received: by me22564.mailengine1.com (PowerMTA(TM) v3.5r14) id hpg93i0j0pku for ; Tue, 23 Feb 2016 00:01:53 -0800 (envelope-from ) MIME-Version: 1.0 X-Mailer: StreamSend2 - 351669 X-Mailer-Version: 2.0 X-Mailer-Environment: production X-Report-Abuse-At: abuse@streamsend.com X-Report-Abuse-Info: It is important to please include full email headers in the report X-rpcampaign: StreamSend26078053 X-Streamsend2id: 351669+1+8392467+26078053+me22564.mailengine1.com Date: Tue, 23 Feb 2016 00:00:14 -0800 From: "The European Prefilled Syringes Summit" Reply-To: "Mohammad Ahsan" To: freebsd-virtualization@freebsd.org Subject: London to Host European Prefilled Syringes Summit Message-ID: <100.0.2.11C.1D16E10752C077E.10ABA5@me22564.mailengine1.com> Content-Type: text/plain; charset=utf-8 Content-Transfer-Encoding: quoted-printable X-Content-Filtered-By: Mailman/MimeDel 2.1.20 X-BeenThere: freebsd-virtualization@freebsd.org X-Mailman-Version: 2.1.20 Precedence: list List-Id: "Discussion of various virtualization techniques FreeBSD supports." List-Unsubscribe: , List-Archive: List-Post: List-Help: List-Subscribe: , X-List-Received-Date: Tue, 23 Feb 2016 08:03:16 -0000 ACI=E2=80=99s European Prefilled Syringes Summit will be taking place in Lo= ndon, UK, on the 7th =E2=80=93 8th September, 2016.=20 The two day event will provide an exclusive platform for collaboration and = discussion between a variety of industry perspectives including manufacture= rs, suppliers, academia and regulators homing in on the latest opportunitie= s arising from new Biological Medicines.=20 The aim is to identify potential solutions, future work programmes and prod= uctive partnerships that overcome the key regulatory challenges and facilit= ate minimizing risk within the supply chain promoting access to safe and ef= fective biologicals. Join us in London to exchange your point of view with your peers and engage= in excellent networking opportunities. For more information, Contact: Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.co.uk=20 Early Confirmed Speakers Include: Thomas Fischer, Senior Quality Manager Medical Device, Novartis Hadj Latreche, Combination Products (Medical Device & Drug) Methods, Proces= s and Infrastructure Group Leader, Roche Pharmaceuticals Ian Thompson, Vice President Business Development, Ypsomed AG Fabien Roy, Senior Associate, Hogan Lovells Martin Murphy, Marketing Lead MedTech Division, Cambridge Consultants=20 Andy Varde, Director of Research & Development, Owen Mumford Key Topics Include: - What issues decide the future of the industry and market - Incorporating human factor engineering into a patient-centric device - Ensure commercial competitiveness of PFS as a drug device - Assess trends of combination products and impacts on PFS - Best practices for the challenging molecular properties: Smart packaging = solutions for highly sensitive compounds - Injectable drug selection criteria - Rethinking approaches to formulation alongside integrating it into manufa= cturing operations - Learn about the latest cutting edge technological developments to acceler= ate your PFS development - Hear from Cambridge Consultants on next generation design devices includi= ng platforms, pumps and featured functionality that works for value chain - Improving cost control through manufacturing in customisable disposable d= evices - Developing strategies to de-risk its supply chain logistics - Next generation smart devices showcase: demonstrating usability and techn= ology advances - Prospects for applications in prefilled technology =E2=80=93 anticipating= requirements for the future Who Will Attend? Senior management within: Head of Device Development Head of Global Product Management Head of Human Factors Senior Application Specialists Senior Packaging Engineers Manager, Finished Products and Medical Devices Head of Device and Delivery Injectables Senior Director, Packaging Head of Medical Devices and Finished Products Register Now to Take Advantage of The 20% Early Bird Discount null Discounted Price: =C2=A31195 (ex.VAT) Standard Price: =C2=A31,495 (ex.VAT). To confirm your participation Contact: Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.net Exhibition & Sponsorship: A wide range of opportunities are available, all of which can be finely tun= ed to match your exact requirements.=20 Tim Rowley-Evans T: +44 (0) 203 141 0637 =20=20 Speaking Opportunities: If you would like to be considered as a speaker at this event please submit= your abstract to: Chloe Wates T: +44 (0) 203 141 0638 null Registration & Media Partnerships: Mohammad Ahsan T: +44 (0) 203 141 0606 Conference Location: London, UK null Active Communications Europe Ltd. www.wplgroup.com | mahsan@acieu.net Sales and Support: +44 (0) 203-141-0606 -- 5/13 Great Suffolk Str. London, SE1 0NS United Kingdom -- http://app.streamsend.com/private/Cwfm/y2j/qwmd1lL/unsubscribe/26= 078053=